SCHEDULE 13G/A: ARK Investment Management Discloses Significant 5.67% Stake in CareDx, Inc.
Beneficial Ownership Disclosure
ARK Investment Management LLC has disclosed a 5.67% beneficial ownership stake in CareDx, Inc., holding 2,988,597 shares of common stock as of September 30, 2024.
Summary
- ARK Investment Management LLC, an investment adviser based in Delaware, has filed a Schedule 13G indicating beneficial ownership in CareDx, Inc.
- As of September 30, 2024, ARK Investment Management LLC beneficially owned 2,988,597 shares of CareDx, Inc. Common Stock.
- This ownership represents 5.67% of the total class of securities outstanding.
- ARK Investment Management LLC holds sole voting power and sole dispositive power over all 2,988,597 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of CareDx, Inc.
Sentiment
Score: 7
Explanation: The disclosure of a significant stake by a prominent investment firm like ARK Investment Management can be viewed positively by the market, indicating confidence in CareDx, Inc.
Positives
- The disclosure of a significant 5.67% stake by a prominent investment firm like ARK Investment Management LLC can be interpreted as a vote of confidence in CareDx, Inc.'s future prospects and business model.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding CareDx, Inc.'s future performance or outlook.
Industry Context
ARK Investment Management is known for its focus on disruptive innovation across various sectors, including healthcare and biotechnology. Their significant stake in CareDx, a company specializing in transplant diagnostics and digital health, aligns with ARK's investment philosophy of identifying companies at the forefront of technological advancement in their respective industries.
Stakeholder Impact
- Shareholders may perceive this as a positive signal, potentially increasing investor confidence and interest in CareDx, Inc.'s stock.
- The company's management might view this as validation of their strategic direction and market position.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of the event which required the filing of this statement (beneficial ownership calculation date). |
| 01/10/2025 | Date the Schedule 13G filing was signed and submitted. |
Keywords
CareDx Inc, ARK Investment Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Healthcare, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.